Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: A quantitative autoradiographic study

Histochemical Journal

Volumn 28, Issue 11, 1996, Pages 791-799

  Schotte, A ^a   Janssen, P F M ^a   Bonaventure, P ^a   Leysen, J E ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; BUTACLAMOL; CLOZAPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PERGOLIDE; QUETIAPINE; REMOXIPRIDE; RESERPINE; RISPERIDONE; SERTINDOLE; SPIPERONE; SULPIRIDE; TETRABENAZINE; ZOTEPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029802407     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02272152     Document Type: Article

References (25)

1. 125]iodosulpride. Neuroscience, 20, 117-55.
2. 2 receptor mRNA. Brain Res. 564, 203-19.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-108.
4. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648, 222-8.
5. KEBABIAN, J. W. & CALNE, D. B. (1979) Multiple receptors for dopamine. Nature, 227, 93-6.
6. 123I]trans-7-OH-PIPAT. Eur. J. Pharmacol. 235, 165-6.
7. 3 receptor mRNA and binding sites in human brain. Mol. Brain Res. 18, 187-92.
8. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89, 8155-9.
9. LEYSEN, J. E., GOMMEREN, W. & LADURON, P. M. (1978) Spiperone, a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro receptor binding. Biochem. Pharmacol. 27, 307-16.
10. LEYSEN, J. E., WYNANTS, J., EENS, A. & JANSSEN, P. A. J. (1989) Ketanserin reduces a particular monamine pool in peripheral tissues. Mol. Pharmacol. 35, 375-80.
11. 3 receptor mRNA's in human and rat brain. Neurochem. Int. 20, 33S-43S.
12. 125I]epidepride. Eur. J. Pharmacol. 227, 443-5.
13. OESTREICHER, E. G. & PINTO, G. F. (1987) A microcomputer program for fitting enzyme inhibition equations. Comput. Biol. Med. 17, 317-21.
14. PAXINOS, G. & WATSON, C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Sydney: Academic Press.
15. RAMM, P. (1994) Advanced image analysis systems in cell, molecular and neurobiology applications. J. Neurosci. Meth. 54, 131-49.
16. SCHOTTE, A., DE BRUYKERE, K., JANSSEN, P. F. M. & LEYSEN, J. E. (1989) Receptor occupancy by ritanserin and risperidone measured by ex vivo autoradiography. Brain Ref. 500, 295-301.
17. 3 receptors in vivo. Eur. J. Pharmacol. 218, 373-5.
18. SCHOTTE, A., JANSSEN, P. F. M., GOMMEREN, W., LUYTEN, W. H. M. L., VAN GOMPEL, P., LESAGE, A. S., DE LOORE, K. & LEYSEN, J. E. (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmncol. 124, 57-73.
19. 3 receptor: Basic and clinical aspects. Clin. Neuropharmacol. 16, 295-314.
20. SEEMAN, P. (1981) Brain dopamine receptors. Pharmacol. Rev. 32, 229-313.
21. 3) as a target for neuroleptics. Nature 347, 146-50.
22. STOOF, J. C. & KEBABIAN, J. W. (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35, 2281-96.
23. 1. Nature 350, 614-9.
24. VAN ROSSUM, J. M. (1966) The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. Ther. 160, 492-4.
25. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-4.